Robertson Stephens Wealth Management LLC Decreases Holdings in Danaher Corporation (NYSE:DHR)

Robertson Stephens Wealth Management LLC reduced its stake in Danaher Corporation (NYSE:DHR - Free Report) by 7.7% during the first quarter, according to its most recent filing with the SEC. The fund owned 15,915 shares of the conglomerate's stock after selling 1,325 shares during the quarter. Robertson Stephens Wealth Management LLC's holdings in Danaher were worth $3,268,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at $27,000. Strategic Financial Concepts LLC bought a new position in shares of Danaher during the 4th quarter worth $31,000. Rialto Wealth Management LLC purchased a new stake in Danaher in the 4th quarter worth about $34,000. Hurley Capital LLC bought a new stake in Danaher in the 4th quarter valued at about $34,000. Finally, Ameriflex Group Inc. purchased a new stake in Danaher during the fourth quarter valued at about $38,000. Institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

Shares of DHR opened at $195.81 on Wednesday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market cap of $140.13 billion, a PE ratio of 38.02, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77. The stock has a 50-day moving average price of $193.42 and a 200-day moving average price of $210.43.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Evercore ISI reduced their target price on shares of Danaher from $240.00 to $230.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. The Goldman Sachs Group cut their price objective on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. UBS Group reduced their price objective on shares of Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft dropped their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, TD Cowen raised their price target on Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $248.17.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.